Photo taken from C. Jillian Tsai/X
Feb 22, 2024, 11:12
C. Jillian Tsai: CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN
C. Jillian Tsai, Radiation Oncologist at Princess Margaret Cancer Centre, Toronto, Canada, shared a post on X/Twitter:
“CURB2 Ph3 RCT approved by NCI CTEP Clinical Research and will be opened through NCTN. (F/u of Ph2 CURB RCT The Lancet”
Source: C. Jillian Tsai/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 17, 2025, 18:14
Jan 17, 2025, 18:02
Jan 17, 2025, 17:53
Jan 17, 2025, 17:45
Jan 17, 2025, 17:28
Jan 17, 2025, 17:20
Jan 17, 2025, 17:15
Jan 17, 2025, 17:11
Jan 17, 2025, 17:03